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The incidence of malignant melanoma, the most dangerous form of skin cancer, is rising each year. However, some aspects of the
tumor initiation and development are still unclear, and the current method of diagnosis, based on the visual aspect of the tumor,
shows limitations. For these reasons, developments of new techniques are ongoing to improve basic knowledge on the disease and
diagnosis of tumors in individual patients. This paper shows how electron paramagnetic resonance (EPR), a method able to detect
free radicals trapped in melanin pigments, has recently brought its unique value to this speciﬁc ﬁeld. The general principles of the
method and the convenience of melanin as an endogenous substrate for EPR measurements are explained. Then, the way by which
EPR has recently helped to assess the contribution of ultraviolet rays (UVA and UVB) to the initiation of melanoma is described.
Finally,wedescribetheimprovementsofEPRspectrometryandimaginginthedetectionandmappingofmelaninpigmentsinside
ex vivo and in vivo melanomas. We discuss how these advances might improve the diagnosis of this skin cancer and point out the
present capabilities and limitations of the method.
1.Introduction
Malignant melanoma is a skin tumor characterized by the
uncontrolled proliferation of melanocytes. This tumor is
the most dangerous form of skin cancer and is responsible
of 3 of 4 deaths linked to a skin cancer. The incidence of
malignant melanoma is rising each year [1, 2], and, nowa-
days, the cumulative lifetime risk for an invasive melanoma
is estimated at 1/59 in the USA A link between sunlight
exposure and melanoma causation has been for a long
time established [3–5]; however, it is still not clear how
the diﬀerent ultraviolet wavelengths (UVA and UVB) are
implicated [6]. The role of melanin as a possible endogenous
photosensitizer is also subject to discussion. This discussion
and the way that a new measurement method based on
electron paramagnetic resonance (EPR) might answer to it
will be explained and debated.
The abilities and perspectives of EPR spectrometry and
imaging as a detection method for melanin pigments, and
consequently for pigmented melanomas, will be also dis-
cussed. Indeed, for now the only method used by dermatol-
ogists for suspecting melanoma is an optical examination of
the lesion based on the detection of ﬁve factors: Asymmetry,
irregular Borders, nonhomogenous Color, large Diameter,
and Evolving (also known as the ABCDE rule). This optical
examination, even if eﬀective, shows limitations: it does not
provide any information about the penetration of the tumor
in the skin, which is a crucial factor to determine the growth
state of the potential melanoma and to provide an adapted
treatment. The use of EPR imaging for the mapping of free
radicals trapped in melanin might allow ﬁlling in this lack of
spatial information in a noninvasive way.
2. A Few Words about Melanin(s)
Melanin is the most widespread pigment in the epithelia of
vertebrates. This molecule is responsible of the pigmentation
of skin, hair, and eye. Historically, its name comes from the2 Journal of Skin Cancer
Greek word melanos that means “dark”. The origin of this
name is generally attributed to the Swedish chemist Berzelius
[7]. As explained by Riley in his review about melanin [8],
the term “melanin” has been used fairly indiscriminately
to mean any dark pigment but the nomenclature has been
reﬁned in the case of mammalian melanin. Indeed, later,
two major diﬀerent kinds of melanin have been described:
eumelanin and pheomelanin. Eumelanin is a brown-black
pigment derived from the enzymatic oxidation of tyrosine
through 3,4-dihydroxyphenylalanine (dopa) [9], while phe-
omelanin is a yellow reddish-brown pigment following a
similar synthesis pathway but including cysteine [10]. How-
ever, it is generally accepted that pure eumelanin or pure
pheomelanin is rare in normal tissues. Most of the time,
eumelaninandpheomelaninmonomersarelinkedinvarious
proportions to create the melanin macromolecules [11, 12].
The melanin polymer has some interesting properties
among which light absorbance, redox properties, and chelat-
ing properties [8]. The wide spectral absorbance of light is
linked to the high degree of conjugation in the molecule.
The redox properties, especially of eumelanins, are caused
by the delocalization of an electron between orthoquinone
and catecholic moieties, which give rise to semiquinone
free radicals (Figure 1). Due to these radicals, melanins can
take part in one-electron and two-electron redox reactions.
This property is responsible of a photooxidation reaction
when the pigment absorbs light and of the photosensitizer
role of melanin, role that will be explained in a dedicated
paragraph of this paper. Moreover, the semiquinone free
radicals trapped in melanin are detectable using EPR. As we
will see later, this makes EPR a unique tool to assess the
extension of melanoma.
3. Paramagnetism and Electron Paramagnetic
Resonance (EPR)
Electron paramagnetic resonance (EPR) is a magnetic res-
onance method similar to nuclear magnetic resonance
(NMR) which focuses on the detection of paramagnetic
materials. The paramagnetism notion refers to the behavior
of a material substrate that does not possess spontaneous
magnetization but, under an external magnetic ﬁeld, ac-
quires a magnetization parallel to this magnetic ﬁeld. This
phenomenon, explained by the quantum physics principles
[13], results from the properties of the electron spin [14]. It
is important to note that only the unpaired electrons might
move from a low energy level to a higher (and vice versa)
and enter into resonance. EPR spectrometry is a method
that detects the absorption of energy linked to the resonance
phenomenon. The quantity of this energy diﬀers in function
of the kind of radicals and their environment. Consequently,
this technique is able to detect and characterize free radicals
by providing spectra which are speciﬁc to the radicals
detected.
Although the EPR technique is similar to NMR, there
are two notable diﬀerences between them [16]. First, the
gyromagnetic ratio of an unpaired electron is largely higher





Figure 1: Semiquinone radical trapped in melanin, responsible of
the paramagnetic properties of the molecule.
spectrometers have to operate at much higher frequencies
and lower ﬁelds than conventional NMR spectrometers.
When working at such high frequencies (typically, 9GHz,
which is a standard frequency used in the most usual EPR
spectrometer), the nonresonant absorption of the electro-
magnetic radiation by the liquid water of the biological
samples presents a serious problem. At 9GHz (X-Band
mode), the microwaves will only penetrate up to 1mm
inside a biological water-containing sample. Larger aqueous
samples or animals can be studied only by reducing the
operating frequency to 1GHz (L-Band mode) or less. At
this frequency, the penetration of microwaves is about 1cm,
which can be convenient for studies on small samples, small
animals, or superﬁcial tissues such as skin. However, this
results in an important loss of sensitivity.
The second major diﬀerence between EPR and NMR
comes from the diﬀerence of their relaxation time, which is
in the range of nanoseconds for electron and in the range
of milliseconds for proton. This has two consequences: ﬁrst,
in vivo EPR spectra are mostly obtained through continuous
wave (CW) experiments, whereas, in clinical MRI, results are
always obtained with the use of pulsed radiowave. Second,
compared to MRI, EPR imaging requires a gradient ﬁeld at
least one order of magnitude greater.
During the last 60 years, EPR spectrometry has been
successfully used in many parts of the scientiﬁc research,
especially in biology where it contributed to the understand-
ing of a large number of physiological processes. The ﬁelds
whereEPRhasbeenthemostusedandusefulalreadypossess
their own review(s), such as the study of iron-containing
molecules [17], the assessment of oxygen concentration in
tumors [16, 18], the detection of reactive nitrogen and
oxygen species in vivo [19, 20], or the assessment of redox
state in biological tissues in vivo [21].
A more recent method derived from EPR spectroscopy,
called EPR imaging, consists in adding an external gra-
dient ﬁeld that modulates the resonance frequency of the
paramagnetic species in function of their position in space
[22, 23]. As a consequence, it is possible to get 2D and
3D maps of the distribution of free radicals. This ability
has, for example, been used, alone or coupled, with another
technology, to improve our knowledge of the brain redox
state [24], measure venous and arterial oxygenation [25],
monitor the evolution of tumor oxygenation after treatment
[26,27],ormaptherepartitionofradio-inducedfreeradicals
after irradiation [28].Journal of Skin Cancer 3
Because in 1954, melanin was found to contain stable
free radicals detectable by EPR [29] and that these radicals
provided a speciﬁc EPR spectrum (Figure 2), this molecule
became a very interesting substrate for further spectrometry
andimagingstudies.Foralongtime,thesetwomethods,and
especially spectrometry, have been used to try to determine
the structure of melanin, to understand the mechanisms
behind its protective role against sunlight aggressions, and
to improve our knowledge of melanoma.
4.Melanin,UVRays,andEPR
An excellent extensive review of this topic (putting together
melanin pigments, UV irradiation, and EPR spectrometry)
has been published by Lund and Timmins in 2007 [6]. We
brieﬂy summarize here the research advances in this ﬁeld.
The role of melanin in the protection of skin from light
radiations has been generally accepted for a long time.
Indeed, a link between melanoma causation and exposure to
sunlight has been observed [3–5]. However, it is unclear how
ultraviolet (UV) rays of sunlight might cause melanoma.
The two major types of UVs, UVA and UVB, seem to have
diﬀerent eﬀects on the causation of the development on this
tumor, but the role of each of them on the initiation of the
tumor is still debated. The resolution of this question could
have important consequences, both in term of recommen-
dations of sanitary authorities and development of eﬀective
sunscreens.Thediscussionissocontroversialthatfewstudies
even brought the beneﬁts of sunscreens into question and
explained that, due to a nonprotection against UVA, they
might be ineﬀective [30, 31] and, as a indirect consequence,
contribute to increase melanoma incidence [32, 33]. Some
other epidemiological studies suggested that both UVA and
UVB were involved in melanoma causation[34–37],whereas
nonmelanoma skin cancers have primarily linked to UVB
[38]. These results suggest that melanin could play a role in
the melanoma sensitization to UVA.
This role of melanin was put in evidence when Sarna and
Sealy demonstrated that the exposition of melanin to UV
and blue light generates reactive melanin radicals (RMRs).
Moreover, it was demonstrated that RMR could react with
biomolecules and molecular oxygen [39, 40] to lead to the
formation of oxygen reactive species, such as superoxide,
leading to hydrogen peroxide and hydroxyl radical.
An EPR technique was recently developed by Wood et
al. [41] to enable accurate measurement of RMR in situ
in skin. This method was used to assess quantitatively the
R M Rf o r m a t i o ni nf u n c t i o no ft h ee x p o s i t i o nt od i ﬀerent
wavelengthintheskinofamousemodelforwhichtheaction
spectrum was already known [30]. They observed that the
2 action spectra were identical from 303 to 434nm, a range
spanning both UVB and UVA. This result demonstrated that
the EPR measurement of reactive melanin radicals could act
as good indicator to determine the contribution of UVA and
UVB in melanoma causation. In this study, it was shown
that over 95% of measured RMR were caused by UVA,
with less than 5% by UVB. Consequently, a sunscreen that
would block the major part of UVB, but would be ineﬀective
g = 2.003
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Figure 2: Typical EPR spectrum of melanin. This spectrum was
obtained for measurement of 5µg of synthetic melanin.
versusUVA,wouldoﬀerverylimitedprotectionagainstRMR
formation.
T h e s er e s u l t ss t i l lh a v et ob ec o n ﬁ r m e do no t h e ra n i m a l
species (including human), and we can predict that the
controversy about UVA, UVB, and melanoma is far away
from the end, but these preliminary results could bring the
outcome faster than expected.
5.The DetectionandGrowthState
Assessment of Melanoma by EPR
The ﬁrst important work concerning the quantitative detec-
tion of melanin by EPR spectrometry inside melanoma sam-
ples was published by Elek et al. in 1980. When measuring
ocular melanomas embedded in paraﬃn, they observed a
free-radicalsignalsituatedatg-factor =2.003,corresponding
to the EPR signal of melanin [42]. When comparing the
amplitudeofthissignalwiththenumberofmelaningranules
observed in histological sections, they observed a straight
positive correlation. They concluded from this experiment
that EPR spectrometry might be suitable for estimating the
melanin content inside melanoma samples.
This study was followed in 1990 by Katsuda et al. who
adapted a self-made EPR cavity to an EPR imaging device
and managed to get the ﬁrst EPR image of endogenous
pigments inside ex vivo melanoma [43]. However, an EPR
image of melanoma had been obtained in vivo three years
before by injecting a paramagnetic nitroxide contrast agent
[44] near the tumor. This image was actually the ﬁrst EPR
image of melanoma but was not the reproduction of the
repartition of melanin, but of the nitroxide contrast agent.
In 2005, after many years of work using EPR to study the
properties of melanin and the eﬀects of UV’s on melanin and
melanoma development, Timmins had the premention that
EPR imaging could be helpful in the melanoma diagnosis
and submitted a patent for the general concept of “detecting
melanin by EPR” [45].
In 2008, Vanea et al. [15] assessed the potential of EPR





Figure 3: (a, b) Melanoma B16 metastases in the lungs of mice: picture of freeze-dried lungs with metastases (a) and the respective 2D
transversal EPR image (b). (c, d) 2D EPR image through a section of thickness 500mm of a paraﬃn-embedded human melanoma (d)
and the histological section (5mm thick) from a contiguous slice (c). Scale bars: 1mm. (e, f) In vivo studies on B16 melanoma in mice.
Melanoma grown in subcutaneous tissue (e) and in vivo EPR image obtained using a low-frequency EPR spectrometer with a head-coil
loop-gap resonator. Scale bar: 2mm. Pictures coming from Vanea et al. [15].
metastases. The freeze-drying process was required to avoid
a nonresonant absorption of the microwaves by the water in
the 9GHz EPR system. They observed that the 2D and 3D
EPR images were ﬁtting very well with the visual aspect of
the melanoma samples and invaded lungs (Figures 3(a), and
3(b)).
In the same study, they adapted their method to the
measurement of paraﬃn-embedded human melanomas. As
a result, they were able to correlate EPR images of these
human melanomas with contiguous histological sections
coming from the same tumors (Figures 3(c), and 3(d)) and
demonstrate fair accuracy of EPR imaging.
In the ﬁnal part of their work, they were able to obtain an
EPR image in vivo of a large mouse melanoma B16 model,
using a low microwave frequency EPR imager. This image
wastheﬁrstEPRimageoftheendogenousmelaninpigments
inside of an in vivo melanoma (Figures 3(e), and 3(f)).
Consecutively to the work of Vanea et al., it was decided
to investigate the relationship between the growth state of
mouse B16 cutaneous melanomas or metastases expressing
luciferase, measured by the bioluminescence imaging (BLI)
technique and their EPR spectra [15, 46]. In this study, we
showed that there was a straight correlation between the EPR
intensity of the signal, reﬂecting the melanin content of the
tumor or invaded lung, and the bioluminescence intensity
corresponding to the same sample. The same study was
made on KHT ﬁbrosarcomas (nonpigmented) so that the
predominantroleofthepresenceofmelaninonthespectrum
was conﬁrmed.
By comparing the two methods, it was moreover demon-
strated that EPR spectrometry was more accurate than
BLI in terms of assessment of the tumoral growth level.
These results, even if very encouraging, might however be
moderated as BLI measurements were performed in vivo,
while EPR measurements were performed ex vivo.
Finally, the limit of detection of the method in the
present conﬁguration (EPR Bruker E540 Elexsys equipped
with a super high-sensitivity probe for X-Band (9GHz)
measurements and equipped with an E540R23 L-B and
EPR head-coil resonator for L-Band (1.1GHz) was assessed.
This experiment, made in parallel with synthetic melanin
and melanoma powder, allowed us to determine that such
a tiny quantity like 2µg of melanin could be detected ex
vivoin favorable conditions using X-Band EPR spectrometryJournal of Skin Cancer 5
(system dedicated to in vitro or ex vivo studies; large freeze-
dried samples, or aqueous samples with a thickness of les
than 1mm). The detection threshold was however around
103 times higher for L-Band and measurements (adapted
for in vivo studies; 1cm depth penetration). Consequently,
the performances of the method should still be improved to
allow accurate and sensitive measurements in vivo.
6. Discussion and Conclusion
For approximately ﬁfty years, considerable progresses were
performed in the ﬁeld of melanin and melanoma knowl-
edge. These progresses are notably due to advances in bi-
ochemistry, genetics, and molecular biology. Parallel to
these advances, technological developments in the ﬁeld of
magnetic resonance were achieved so that, nowadays, it
is possible to apply the electron paramagnetic resonance
spectroscopy and imaging to the detection of biological-free
radicals, including those trapped in melanins, with a high
sensitivity.
The application of EPR to melanins has led to many
discoveries concerning melanin structure and melanoma
development. As shown by Lund and Timmins [6], EPR
spectrometry appeared as a unique tool to identify the
ultraviolet range responsible of melanoma causation, and,
by the way, to help to resolve a thirty-year-old controversy.
We can expect that the consequences of this demonstration
will have important consequences in the ﬁeld of sunscreen
development, which should undoubtedly contribute to a
reduction of melanoma prevalence.
On the other hand, the improvements achieved in the
ﬁeld of EPR spectrometry during these last years allowed us
tomeasureaccuratelyandsensitivelythepresenceofmelanin
pigments inside melanoma samples. As a straight correlation
wasfoundbetweentheintensityoftheEPRsignalofmelanin
and the tumor growth state, the signal of melanin appears as
a good indicator for melanoma development. Moreover, due
to a continuous improvement of EPR imager performances,
the ﬁrst in vivo mapping of endogenous melanin pigments
insidemelanomacouldrecentlybeachievedbyEPRimaging.
Ongoing researches are now focusing on the characterization
of human melanoma samples by this technique. Indeed,
the diagnosis of melanoma in human by the ABCDE optic
rule, even if eﬀective, does not refer to any objective quan-
tiﬁable standard. Moreover, an important limitation of the
technique is the impossibility to obtain information about
the tumor penetration (Clark’s index) without performing
a biopsy. The use of EPR imaging could ﬁll in these lacks,
that is why this method is at present tested on ex vivo human
melanoma samples with diﬀerent Clark’s index. Applied in
vivo, it would help the surgeon to deﬁne more precisely
the margins for lesions resections, based on a noninvasive
method. Preliminary results are encouraging, but it seems
that early melanomas could provide an EPR signal that is
insuﬃcient for the reconstruction of EPR images. If these
results are conﬁrmed, new technical improvements in terms
of magnetic gradient ﬁeld or EPR cavity should be required
before adapting the method to in vivo measurements.
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